SINGLE
ENZYME
ACTIVITY-BASED
LIQUID
BIOPSY
We revolutionize disease diagnosis and drug development with
'Single Enzyme Activity-based Liquid Biopsy' technology.
News
-
Award
Cosomil Secures Grant from NEDO’s Deep Tech Support Program STS Phase
-
Other
Our Laboratory Achieves Clinical Laboratory Registration
-
Research
Research Achievements Towards Company Founding Published in Cell Reports Methods
-
Research
Cosomil and Takeda Commence Collaboration on Enzyme Activity Biomarker Measurement
Science
We are advancing high-precision liquid-based diagnostics
using 'Single Enzyme Activity-based Protein Profiling (SEAP),'
enabling enzyme activity analysis at single protein level.
Services
Our business tagets early disease detection and drug development support.
Through SEAP technology, we have the potential to detect early-stage pancreatic cancer.
About
We will contribute to future growth of healthcare
by applying fluorescent enzyme substrates and microdevices.